Intercept Pharmaceuticals

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients' lives and addressing the liver community's most pressing needs. Our corporate headquarters is located in New York, and we have additional offices in San Diego, London and Perugia. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on Twitter at: @InterceptPharma.

pharmaceuticals
200 employees
New York, United States
Founded 2002

About Intercept Pharmaceuticals

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients' lives and addressing the liver community's most pressing needs. Our corporate headquarters is located in New York, and we have additional offices in San Diego, London and Perugia. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on Twitter at: @InterceptPharma.

Company Details

Business Type privately-held
Revenue $10M-$50M

Social Media

Technologies

amazon-cloudfront amazon-s3 google-analytics google-tag-manager microsoft-365 [email protected] vite [email protected]

Frequently Asked Questions

What does Intercept Pharmaceuticals do?

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients' lives and addressing the liver community's most pressing needs. Our corporate headquarters is located in New York, and we have additional offices in San Diego, London and Perugia. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on Twitter at: @InterceptPharma.

How can I contact Intercept Pharmaceuticals?

Visit their website at interceptpharma.com for more information.

Where is Intercept Pharmaceuticals located?

New York, United States

What industry is Intercept Pharmaceuticals in?

pharmaceuticals

How many employees does Intercept Pharmaceuticals have?

200

When was Intercept Pharmaceuticals founded?

2002

Looking for More Company Information?

Discover more innovative companies in our comprehensive directory.

Browse All Companies